- Takeda to buy Millennium for $8.2bn in cash
- Takeda buys IDM Pharma for $66.7mm cash
- Millennium to buy AnorMed; outbid
- Genzyme completes acquisition of AnorMed
- Takeda acquires Syrrx
- Millennium in giant cancer deal with Ortho Biotech
- Takeda gets Japanese rights to 13 Amgen compounds
- Takeda signs RNAi deal with Alnylam
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. email@example.com.
All fields are required.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.